China Biologic Products Analysis
China Biologic Products is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of China Biologic delisted stock analysis is to determine its intrinsic value, which is an estimate of what China Biologic Products is worth, separate from its market price. There are two main types of China Biologic's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect China Biologic's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of China Biologic's stock to identify patterns and trends that may indicate its future price movements.
The China Biologic stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. China Biologic is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. China Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and China Biologic's ongoing operational relationships across important fundamental and technical indicators.
China |
China Stock Analysis Notes
About 45.0% of the company shares are held by company insiders. The book value of China Biologic was currently reported as 51.12. The company has Price/Earnings To Growth (PEG) ratio of 1.84. China Biologic Products had not issued any dividends in recent years. China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the Peoples Republic of China. China Biologic Products Holdings, Inc. is headquartered in Beijing, the Peoples Republic of China. China Biologic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. For more info on China Biologic Products please contact David Gao at (86) 10 6598 3222 or go to www.chinabiologic.com.China Biologic Products Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. China Biologic's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding China Biologic Products or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| China Biologic is not yet fully synchronised with the market data | |
| China Biologic has some characteristics of a very speculative penny stock | |
| China Biologic has a very high chance of going through financial distress in the upcoming years | |
| About 45.0% of the company shares are held by company insiders |
China Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.65 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate China Biologic's market, we take the total number of its shares issued and multiply it by China Biologic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.China Profitablity
China Biologic's profitability indicators refer to fundamental financial ratios that showcase China Biologic's ability to generate income relative to its revenue or operating costs. If, let's say, China Biologic is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, China Biologic's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of China Biologic's profitability requires more research than a typical breakdown of China Biologic's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 29.04 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 37.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $37.26.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding China Biologic to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in China Stock
If you are still planning to invest in China Biologic Products check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Biologic's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |